Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8788 |
High Similarity |
NPD1240 |
Approved |
0.8667 |
High Similarity |
NPD1510 |
Phase 2 |
0.8657 |
High Similarity |
NPD1607 |
Approved |
0.8636 |
High Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8478 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8467 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8406 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8406 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8252 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8227 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8227 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8203 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.8201 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8182 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8125 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8095 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8092 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.8074 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8071 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8067 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8041 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8028 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7958 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7956 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7955 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7947 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7933 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7933 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7895 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7881 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7872 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7867 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7852 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7852 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7852 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7829 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7815 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7815 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7812 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.781 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7808 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7786 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7778 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.777 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7754 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7748 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.773 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7724 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7724 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7703 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7698 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7682 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.766 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7651 |
Intermediate Similarity |
NPD920 |
Approved |
0.7647 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7635 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7635 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7635 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7635 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7634 |
Intermediate Similarity |
NPD9493 |
Approved |
0.763 |
Intermediate Similarity |
NPD9717 |
Approved |
0.763 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7622 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7609 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7595 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7589 |
Intermediate Similarity |
NPD943 |
Approved |
0.758 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7574 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7571 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7571 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7571 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7569 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7569 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7548 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7536 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7535 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7535 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7534 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7532 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7532 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7531 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7519 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7517 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7517 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD940 |
Approved |
0.75 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD846 |
Approved |
0.7484 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7484 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7481 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7469 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7465 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7465 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7453 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.745 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7438 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7429 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7426 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7426 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7417 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7415 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7413 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7405 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7403 |
Intermediate Similarity |
NPD37 |
Approved |
0.7397 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7391 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7379 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7376 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7372 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7365 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7357 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7357 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7346 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7346 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7346 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7342 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7338 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7338 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7333 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.7324 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7319 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7315 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7313 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7308 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7305 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7301 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7297 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7297 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7292 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7286 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7285 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7266 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7266 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7261 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7261 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7261 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7256 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7244 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7234 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7212 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7211 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7209 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7208 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7206 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7203 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7194 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7194 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7194 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7172 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7172 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7171 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.717 |
Intermediate Similarity |
NPD919 |
Approved |
0.7169 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7169 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7169 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7163 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7154 |
Intermediate Similarity |
NPD2934 |
Approved |
0.7154 |
Intermediate Similarity |
NPD2933 |
Approved |
0.7153 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7153 |
Intermediate Similarity |
NPD17 |
Approved |
0.7153 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7440 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7132 |
Intermediate Similarity |
NPD968 |
Approved |
0.7122 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7114 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7103 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7101 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7099 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD2859 |
Approved |
0.7097 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7097 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7097 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7092 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7092 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7083 |
Intermediate Similarity |
NPD411 |
Approved |
0.7081 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7077 |
Intermediate Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.7068 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7055 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.705 |
Intermediate Similarity |
NPD1281 |
Approved |
0.705
|
Intermediate Similarity |
NPD1091 |
Approved |